Cohort Study of Heart Failure With Preserved Ejection Fraction in Chinese Han

Last updated: March 3, 2022
Sponsor: Nanjing First Hospital, Nanjing Medical University
Overall Status: Active - Recruiting

Phase

N/A

Condition

Chest Pain

Congestive Heart Failure

Heart Failure

Treatment

N/A

Clinical Study ID

NCT05278026
ChiHFpEF-Cohort
  • Ages > 18
  • All Genders

Study Summary

To analyze factors contributing to the development and prognosis of heart failure with preserved ejection fraction.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Patients with CVD, defined as at least one diagnosis of coronary heart disease,hypertension, type 2 diabetes or cardiomyopathy. The definition of coronary heartdisease was stenosis of the main coronary arteries ≥ 50% using percutaneous coronaryangiography or coronary computed tomography angiography findings. The definition ofhypertension was systolic blood pressure ≥ 140 mmHg, diastolic blood pressure ≥ 90mmHg or pharmacological treatment. The definition of type 2 diabetes was fasting bloodglucose ≥ 7.0 mmol/L, random blood glucose ≥ 11.1 mmol/L and HbA1c > 6.5% or the orthe use of hypoglycaemic medications. Cardiomyopathy was defined as the presence ofcardiac insufficiency in patients with dilated cardiomyopathy suggested bypercutaneous coronary angiography or coronary CT angiography use of hypoglycaemicmedications.

Exclusion

Exclusion Criteria:

  • primary diagnoses of atherosclerosis (stenosis of the main coronary arteries < 50%),congenital heart diseases, arrhythmia, lung diseases, aortic dissection, peripheralvascular diseases, pericardial diseases, myocarditis, hypertrophic cardiomyopathy,heart valvular diseases, cardiophobia, costal chondritis, shock, thyroid diseases,infection or concomitant liver or renal dysfunction.

Study Design

Total Participants: 2000
Study Start date:
January 01, 2014
Estimated Completion Date:
January 01, 2026

Study Description

Based on previous studies on development of heart failure with preserved ejection fraction (HFpEF), racial/ethnical background should be underscored when evaluating risk f actors for HFpEF incidence. As the ageing population increases sharply in China, HFpEF represents the dominant phenotype of all patients diagnosed with heart failure. In this cohort study, the investigators evaluated exposures or risk factors for HFpEF in Chinese Han patients with cardiovascular diseases (CVD). Our study may provide preventive and therapeutic targets for HFpEF in Chinese CVD patients.

Connect with a study center

  • Nanjing First Hospital

    Nanjing, Jiangsu 210006
    China

    Active - Recruiting

Map preview placeholder

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.